Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Fox

Showing results (331-340 of 1,557) with videos related to

Pageof 156
Sort By:
Nature Biotechnology|June 9, 2012
Shire drops 'emergency' Fabry's disease drugJeffrey L Fox
Nature Biotechnology|May 1, 1996
Surreal US budget again favors R&D spendingJ L Fox
Nature Biotechnology|October 1, 1996
Another genome, another kingdom, another set of surprisesJ L Fox
Bio/Technology (Nature Publishing Company)|November 1, 1995
Pinning down a moving target: a standard HIVJ L Fox
Nature Biotechnology|November 5, 2003
Concerns raised over declining antiinfectives R&DJeffrey L Fox
Nature Biotechnology|December 16, 1998
Monsanto unaffected by merger halt?J L Fox
Nature Biotechnology|April 1, 1997
Green light for gene therapy in healthy volunteersJ L Fox
Nature Biotechnology|March 3, 1999
Delegates face many challenges negotiating Biosafety ProtocolJ L Fox
Nature Biotechnology|May 10, 2013
FDA moves on breakthrough therapiesJeffrey L Fox
Nature Biotechnology|May 10, 2013
Antimicrobial peptides stage a comebackJeffrey L Fox
Pageof 156

Showing results (331-340 of 1,557) with videos related to

Sort By:
Pageof 156
Nature Biotechnology|June 9, 2012
Shire drops 'emergency' Fabry's disease drugJeffrey L Fox
Nature Biotechnology|May 1, 1996
Surreal US budget again favors R&D spendingJ L Fox
Nature Biotechnology|October 1, 1996
Another genome, another kingdom, another set of surprisesJ L Fox
Bio/Technology (Nature Publishing Company)|November 1, 1995
Pinning down a moving target: a standard HIVJ L Fox
Nature Biotechnology|November 5, 2003
Concerns raised over declining antiinfectives R&DJeffrey L Fox
Nature Biotechnology|December 16, 1998
Monsanto unaffected by merger halt?J L Fox
Nature Biotechnology|April 1, 1997
Green light for gene therapy in healthy volunteersJ L Fox
Nature Biotechnology|March 3, 1999
Delegates face many challenges negotiating Biosafety ProtocolJ L Fox
Nature Biotechnology|May 10, 2013
FDA moves on breakthrough therapiesJeffrey L Fox
Nature Biotechnology|May 10, 2013
Antimicrobial peptides stage a comebackJeffrey L Fox
Pageof 156